iBio Statistics

Share Statistics

iBio has 16.22M shares outstanding. The number of shares has increased by 88.08% in one year.

Shares Outstanding	16.22M
Shares Change (YoY)	88.08%
Shares Change (QoQ)	64.25%
Owned by Institutions (%)	26.23%
Shares Floating	15.31M
Failed to Deliver (FTD) Shares	52,955
FTD / Avg. Volume	2.54%

Short Selling Information

The latest short interest is 468.39K, so 2.89% of the outstanding shares have been sold short.

Short Interest	468.39K
Short % of Shares Out	2.89%
Short % of Float	2.89%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -0.31 and the forward PE ratio is -0.72. iBio's PEG ratio is 0.

PE Ratio	-0.31
Forward PE	-0.72
PS Ratio	34.22
Forward PS	11.8
PB Ratio	0.36
P/FCF Ratio	-0.41
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for iBio.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.21.

Current Ratio	4.08
Quick Ratio	4.08
Debt / Equity	0.21
Debt / EBITDA	-0.32
Debt / FCF	-0.24
Interest Coverage	-96.71

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$14.06K
Profits Per Employee	$-1.56M
Employee Count	16
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by -63.29% in the last 52 weeks. The beta is 0.6, so iBio's price volatility has been higher than the market average.

Beta	0.6
52-Week Price Change	-63.29%
50-Day Moving Average	0.78
200-Day Moving Average	2.24
Relative Strength Index (RSI)	26.95
Average Volume (20 Days)	2,081,241

Income Statement

In the last 12 months, iBio had revenue of 225K and earned -24.91M in profits. Earnings per share was -6.5.

Revenue	225K
Gross Profit	225K
Operating Income	-16.63M
Net Income	-24.91M
EBITDA	-14.02M
EBIT	-15.27M
Earnings Per Share (EPS)	-6.5

Full Income Statement

Balance Sheet

The company has 14.21M in cash and 4.46M in debt, giving a net cash position of 9.75M.

Cash & Cash Equivalents	14.21M
Total Debt	4.46M
Net Cash	9.75M
Retained Earnings	-313.85M
Total Assets	19.1M
Working Capital	663K

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.55M and capital expenditures -210K, giving a free cash flow of -18.76M.

Operating Cash Flow	-18.55M
Capital Expenditures	-210K
Free Cash Flow	-18.76M
FCF Per Share	-4.9

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -7392.89% and -11069.78%.

Gross Margin	100%
Operating Margin	-7392.89%
Pretax Margin	-6863.56%
Profit Margin	-11069.78%
EBITDA Margin	-6231.56%
EBIT Margin	-7392.89%
FCF Margin	-8339.56%

Dividends & Yields

IBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for IBIO is $5.5, which is 848.3% higher than the current price. The consensus rating is "Buy".

Price Target	$5.5
Price Target Difference	848.3%
Analyst Consensus	Buy
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:20.

Last Split Date	Nov 29, 2023
Split Type	backward
Split Ratio	1:20

Scores

Altman Z-Score	-25.99
Piotroski F-Score	2

iBio Inc. (IBIO)